Podcasts about network director

Guest Dr. Sundar Jagannath and host Dr. Davide Soldato discuss JCO article "Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma," and the efficacy of CAR-T cell therapy in patients with heavily pretreated RRMM (relapsed/refractory multiple myeloma). TRANSCRIPT Dr. Davide Soldato: Hello and welcome to JCO After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology. I am your host, Dr. Davide Soldato, medical oncologist at Ospedale San Martino in Genoa, Italy. Today, we are joined by JCO author, Professor Sundar Jagannath, Professor of Medicine at the Icahn School of Medicine at Mount Sinai and the Tisch Cancer Institute. He also serves as Network Director for the Center of Excellence for Multiple Myeloma, and he is an internationally recognized expert in the field of multiple myeloma. Today, we will be discussing the article titled, "Long-Term Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma." Thank you for speaking with us, Professor Jagannath. Dr. Sundar Jagannath: Thank you for having me, Dr. Davide Soldato. It is a pleasure to be here. JCO is a highly recognized journal among the oncologists, so I am very happy and privileged to be here today. Dr. Davide Soldato: Thank you so much for being with us. So, I wanted to start a little bit with the rationale of the study and the population that was included in the study. So, the trial that we are discussing, CARTITUDE-1, was already published before, and we observed very good results with a single infusion of cilta-cel. So we had previously reported a median progression-free survival of 30 months, and median overall survival was not reached. So, I just wanted to ask you if you could guide us a little bit into the population that was included in the study and also explain a little bit to our listeners what is the drug that we are discussing, cilta-cel. Dr. Sundar Jagannath: It is a CAR T-cell. This is a patient's own lymphocytes, which goes through apheresis and is sent to the company, where they modify it and introduce the B cell receptor. In this case, you know, there is a heavy chain gene receptor for the BCMA, and in cilta-cel, there are actually two receptor sites on each molecule, or there are two binding domains on each receptor molecule. So, it is considered to be quite efficacious. As you reported, the earlier results that the patients who participated, 97% of the patient responded. Now, you asked about the patients who participated in the clinical trial. This clinical trial was conducted between July of 2018 and October of 2019. At that time, this was a phase 1b/phase 2 trial, and the whole idea was to take patients who had relapsed all the available treatment regimen so that these patients were considered to have, in the unmet medical need situation. So, what does that entail? That means the patient should have been exposed to a proteasome inhibitor, to an immunomodulatory molecule, and to an anti-CD38 monoclonal antibody and should have received at least three or more prior lines of therapy and should be actually progressing on their last line of therapy. So with that requirement, if you look at it, the median number of prior therapy on the patients who participated was actually six. So patients were heavily pretreated. They had exhausted all available treatment options. So, they can participate in this clinical trial. And if not, there have been real-world evidence, such as LocoMMotion, which had reported what is the outcome for such a patient if they were treated outside of this clinical trial, if they were treated with the then available regimen. Their median progression free survival would have been only 3 months, and most patients would have lost their life within a year. So, this was truly an unmet medical need with patients in a very difficult clinical situation. Let's put it that way. So, those were the patients who participated in this particular trial. Dr. Davide Soldato: Thank you very much. And as we mentioned before, the results that were obtained in this clinical trial were really very interesting. And now, in this issue of the Journal of Clinical Oncology, you are reporting data with a longer follow up. So we are actually at more than 5 years of follow up for the patients included in this trial. So, I just wanted a little bit of insight into why you decided to report these long-term outcomes and what type of information do you think you could provide with this study to the medical community? Dr. Sundar Jagannath: This is very important because this was a clinical trial that was done in patients who were, as I said, in unmet medical need. Most of the patients had prior stem cell transplantation, had gone through a proteasome inhibitor. Many of them have had both Velcade and carfilzomib treatment. Most of them had been exposed to lenalidomide and pomalidomide. And as required, all of the patients had to have had prior exposure to anti-CD38 monoclonal antibody or daratumumab. So, the patients were heavily pretreated. Typically, TIL CAR T-cells came into the field at this particular moment, until then, we were developing small molecules, and they usually would have a PFS of 3 months and median life expectancy of a year, the overall response rate of 30%, and that is how, if you look back, that is how carfilzomib was approved, that is how pomalidomide was approved. So, the drugs which were approved, including daratumumab, you know, the response rate was in the same ballpark. So you would see that most agents, single agents, would have had a response rate in the neighborhood of 30%, the progression-free survival would have been between 3 to 5 months or 6 months at the most, and the life expectancy was short. And here comes a drug, and when I was following the patients at Mount Sinai, I found that there were a subset of patients, they got one-time treatment and they were in complete remission, no trace of cancer with annual evaluation with PET CT and bone marrow evaluation for MRD. So, I said this is remarkable, and this needs to be reported. And I went to the Janssen and company, and they agreed to review the entire experience. This is remarkable that 32 of the 97 patients, or one third of the patients, were alive and progression-free. This is unheard of for any clinical trial until now, that the patient will be progression-free, one third of the patients on a clinical trial will be progression-free, in the late stage of their disease. So that is the most important impact. And that is why this 5-year follow-up results were presented. Dr. Davide Soldato: Thank you very much. That was very clear. And as you said, we are speaking about a population that was heavily pretreated, that had exhausted all type of treatment options outside of a clinical trial. And as you said, one third of the patients was alive and progression-free after 5 years from being included and infused inside of the study. So, considering this population that, as we said, had received all treatment options, I was wondering if you observed any kind of differences in terms of disease characteristics when looking at these patients that had exceptional response, so, alive and progression-free at 5 years, and the patients that sadly had developed a progression after the infusion in the study. Dr. Sundar Jagannath: This is very important because we wanted to see who are the patients who are having this exceptional outcome. And we looked at all the 97 patients. If we look at all the patients, we saw that there were initially, out of the 97, 17 patients died earlier in the disease course due to treatment related complications, etc. But there were about 46 patients who had progression of disease and 32 patients, or one third, were alive without progression of disease. Then we looked at the 46 patients who had progression of disease. Of them, we found that 30 had disease progression and its complication, and there were actually 13 patients who were still alive even after progression of disease. So we decided to compare these 46 patients who had progression of disease versus 32 patients who had no progression of disease to see what is the difference. To our surprise, the age was similar, male, female distribution was similar. High-risk cytogenetics, which we would have thought, you know, that is why we say high-risk disease, the term, high-risk cytogenetics was equally distributed. That was really a surprise. Number of lines of prior therapy, number of exposure to drugs, all of that was the same. So that was also interesting. But a theme did emerge. Patients, in general, tend to have lower burden of disease who had the exceptional outcome. But there is one which we considered as bad, the extramedullary disease. Multiple myeloma being a blood cancer, it is usually in the bone marrow. When it starts growing outside of the bone marrow, the extramedullary disease, usually it portends poor prognosis. But we were surprised that actually there were an equal number of extramedullary disease patients even in the long-term survivor as those who had progressed of disease. So the most important takeaway was patients who had lower burden of disease, they had less number of myeloma cells in their bone marrow, percentage wise, and the soluble BCMA level was lower. Soluble BCMA is an indirect measure of the amount of plasma cells in the patient's body. It is like a tumor burden. So they were low. So, this was an important finding because it has future ramification, as you can understand. If this treatment is made available earlier in the disease course of the patients, where we are able to control the disease better, then more patients are likely to have such wonderful outcomes as one third of the patient experience in the late stage of the disease. Dr. Davide Soldato: So, you already mentioned soluble BCMA as a marker of potentially better prognosis as being correlated to a lower volume of disease. I was wondering if you could give us some more information about the biomarkers that you evaluated in the study. For example, you evaluated a little bit the CAR T expansion kinetics and also some others that I think could be interesting and could point to some population that experienced such important benefit. Dr. Sundar Jagannath: That is a very important point because CAR T-cell, it is a live cell and its efficacy depends upon how well the CAR T-cell is going to function. And then, you know, the patient undergoes apheresis. This is a patient's own lymphocyte. So first and foremost is who would generate good CAR T-cell. Those who have plenty of lymphocytes at the time they are coming for apheresis. This is likely to happen earlier in the course of the disease than in patients who have gone through numerous lines of therapy and exhausted. So, in this particular trial, of course this was in late stage of the disease, and so we were able to show patients who had lower number of T cell in circulation, and the way to measure is if they had more neutrophils and less lymphocytes. So that is what is called as a higher T cell over neutrophil, they did better. If they have more neutrophil than T cells, then they did not do well. So, procurement. The second one is also whether the T cells are more naive, you know, not exhausted T cells. So more naive T cells, if you are able to procure from the patient, they did very well. Now, after the CAR T-cell manufacture, then the expansion, when you put it back into the patient, if the T cells expand very well, so that the effector, that is the CAR T-cells to the tumor ratio is good, so there are more effector cells, the CAR T was able to expand and the amount of tumor was less, then the efficacy was very, very good. As I said, the patients in this group, those who had a lower burden of disease, they did better, and that is because of the CAR T-cell expansion, so the effector to the target ratio was favorable. So that is another important. And then there are also the type of CAR T-cells, having CD4 T cells with central memory phenotype at the peak expansion also makes a difference. So all of that matters. But this is important because the efficacy of the CAR T-cell, it is persistent, long persistent and keeping the cancer down. Its ability to get rid of the cancer completely at the first go around because usually we are not able to detect the CAR T-cells beyond 6 months in the majority of patients and very rarely after a year or two. So it is very uncommon to find the CAR T-cells in circulation or even in the regular bone marrow evaluation. So, efficacy, the expansion, having naive T cells, having good effector to target ratio and more central memory kind of T cell, because if it is all effector T cell, they will get quickly utilized and get exhausted, whereas the central memory cells can expand more and give more effective CAR T-cells. Dr. Davide Soldato: Thank you very much. I was wondering if you could guide us a little bit into what is your opinion regarding the positioning of CAR T-cells given all of these logistics that is necessary compared, for example, with bispecific antibodies against BCMA, which have the same target, but they do not have all of these logistics before being administered to the patient. Dr. Sundar Jagannath: That is a very important question, how to sequence these treatments now that we have two BCMA-directed CAR T-cells available. We have three BCMA-directed bispecific and one GPRC5D-directed bispecific antibodies are available. And so the question comes in for at least the currently approved CAR T-cell therapy, there is an obligatory time. You have to go through apheresis and you have to ship to the company, and there is a manufacturing time, roughly about 2 months before they can receive it. During that time, you want to make sure the patient's disease is under control. So that is a given. There are several ways to look at it when we evaluate the patient and talk to the patient. One good thing is now the two CAR T-cells which are approved, one is cilta-cel we talked about, and the other one is ide-cel. Ide-cel is approved in earlier line of therapy, two or more prior lines of therapy, and cilta-cel is approved in patients who have failed one line of therapy and who are lenalidomide refractory. So, the treatment of CAR T-cell is available earlier. And as I said, when you administer CAR T-cell earlier, you are able to keep the disease burden down, and it is a one and done deal. There is a better quality of life for the patient, and you are able to produce long, durable remission and potentially a cure. Now coming to the bispecific, they are currently available in later lines of therapy. So if you look at it from a patient's perspective, you can use the CAR T-cell earlier and then go through the bispecific therapy. But if the patient comes with relapsed refractory myeloma and has not used the CAR T-cell therapy and has not used the bispecific therapy, then the physicians have to decide which one they want to use. If somebody's disease is rapidly progressing and they need immediate tumor reduction and they have already exhausted all available therapy, then going through BCMA bispecific therapy is quite appropriate. And secondly, CAR T-cell therapy is generally given to somewhat physically more fit patients, whereas bispecific therapy, because you are giving antibody at step-wise dosing in this patient, and you have the ability to stop at any particular dose and then come back and redose, whereas CAR T is, you just give it to them one time, you have a lot more control. So intermediate frail or even frail patients can go through bispecific therapy, whereas it would not be in the best interest of the patient to go through a CAR T-cell therapy when they are frail. So that is another important point. But from the information available, when the patient goes on a BCMA bispecific therapy and they start progressing on treatment, usually it is their T cells are exhausted or the BCMA is no longer expressed on the tumor cells. So coming with CAR T-cell later on is usually not effective, whereas giving CAR T-cell earlier, if the patient relapses later, they have good T-cell function and most of the time the BCMA is still expressed. So you are able to give the BCMA to the maximum benefit by using the CAR T first and BCMA later. So if somebody asked me how to sequence this, just off the bat, you will say CAR T first, BCMA bispecific second. But as I said, there are unique situations. Then there is another potential that is happening. You can change the target. You can use a BCMA against GPRC5D to reduce the tumor, and then go ahead and consolidate it with a CAR T-cell therapy. That is also possible. You are changing the target from GPRC5D to BCMA, the tumor is already down, so the patient is likely to benefit. So these are all newer treatment options which have become available to the physician. So they will have to look at individual patients and decide what is the best course of action for that patient. Dr. Davide Soldato: So, I just wanted to close a little bit with your opinion about how these results translate into clinical practice. So considering this outstanding 5-year data that we have seen, one third of the patients who are alive and progression-free after a single infusion of cilta-cel, do you think that we could start to think about functional cure even in patients who have a diagnosis of relapsed refractory multiple myeloma? Dr. Sundar Jagannath: My feeling is this is important because in this particular study which is published, 12 patients who were followed at Mount Sinai out of the 32 patients who are alive and progression-free, 12 were followed at Mount Sinai. And they were evaluated every year with bone marrow MRD testing by clonoSEQ in 11 of the 12 patients, and one was by multiparametric flow cytometry. So most of them were 10 to the minus 6, not even one in a million cancer cells, and all of them had functional imaging, which is called PET CT every year. So these were patients who had no evidence of disease that we could detect with the technology available today, serologically, in the bone marrow, or anywhere else in the body with a PET CT. They were found to be disease free after a single infusion of cilta-cel. So, that would be almost to the definition of a cure because if you look at cure as a definition for any cancer, cure is defined as a state of complete remission with no trace of cancer that persists over a period of 5 years or longer without maintenance. And that will be applicable for breast cancer, lymphoma, leukemia. So it is a general statement. And if we use that in myeloma too, then I could say that these 12 patients from my center, we proved that they are cured of their myeloma. They are not functionally cured. You've got to remember, there is only cure. That was the definition across all diseases. So there is nothing like a functional cure. They are cured of myeloma. So is myeloma curable? This is the first time we are looking at that. We do know, every physician treating myeloma that there are patients out there, 10 year and beyond, without evidence of disease. This has been published by University of Arkansas, Bart Barlogie's group, who has been saying that myeloma is a curable disease for a long time. And many others have shown long-term follow up. But this one in a late stage disease, we were able to show that they were one treatment with no maintenance. All other studies have been in newly diagnosed myeloma patients. Nobody has shown in late relapse patients on a clinical trial a third of the patient will be progression-free. And 12 of them who were studied were actually disease free. So they were cured of the disease. So if we accept that, then the next question is, first step towards cure is achieving complete remission. They should have no monoclonal protein by any technology you want to use, no measurable residual disease using next gen sequencing or clonoSEQ, and functional imaging whole body PET CT or whole body MRI. So that is important, definition of the complete remission. And then it has to be sustained. That is something the IMWG and IMS, International Myeloma Society, they will have to come together for a consensus. How many years should they be followed and should be in this kind of status with no trace of cancer? Is it, 3 years are enough? 4 years enough? 5 years is enough? For me, I said in this paper, 5 years is a good definition for achieving a potential cure. Then you use the term 'functionally cured'. I have a problem with functionally cured and operationally cured or whatever. Functionally cured was originally put out by Paiva from Spain. There were 8% of newly diagnosed myeloma patients who have, after they go get treated, they will have an MGUS like phenomenon, a small amount of paraprotein detectable, and they are only 8%. And he said that these patients could be off treatment and the disease does not progress. But the problem is when you are giving treatment like maintenance therapy continuously until progression, you do not know exactly who is in the MGUS situation. So you have to have done sophisticated flow cytometry like Paiva did, and it is not quite clinically applicable. So functionally cured applies only for 8% of the people, so it should go out of the vocabulary. Then you can say 'operationally cured'. These are the patients traditionally Bart Barlogie and others showed that they have a large number of patients who have been followed for 10 years with no recurrence of disease, not on treatment. But in those days, they did not have MRD PET CT and all of them done systematically. So that is why they had to come up with a situation where they said they were operationally cured. So yes, myeloma patients have been cured since auto transplant was introduced. I completely agree. It is not new to the CAR T-cell therapy. But the beauty of the CAR T-cell therapy was it was in relapsed refractory myeloma, unmet medical need, number one. Number two, they were studied systematically. It was a clinical trial adjudicated by FDA and EMA for drug approval, cilta-cel was approved. So these patients were carefully followed, and it was a multi-center study. And in that group of patients, we were able to show patients- So, I think this would indicate cure is a reality in myeloma, and as these kind of treatments, immunologic treatment, either it is a CAR T-cell therapy or BCMA bispecific or whatever, there is a chance more patients are likely to be cured, and these treatments have to move forward and so that we are looking towards a cure. That is the beauty of it, and I just thank you for asking and also throwing in this so-called functionally cured, which people like to use casually, and I say it is time to talk more cure and not stuck with functionally cured because that does not allow the field to progress. Dr. Davide Soldato: Thank you very much. That was very interesting. Dr. Sundar Jagannath: And provocative. Dr. Davide Soldato: A little bit, but I think that we needed to close the podcast with this kind of reflection coming from someone who is an expert in the field, as you are. So, I really wanted to thank you for joining us today and for sharing more on your article, which is titled, "Long-Term Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma." If you enjoy our show, please leave us a rating and a review and be sure to come back for another episode. You can find all ASCO shows at asco.org/podcasts. Dr. Sundar Jagannath: Thank you. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.      

With Hot Rod Drag Week 2025 starting on Sept 14, Mike Galimi, the Network Director of Hot Rod Magazine, was on Episode 122 of the Drag Drive Repeat Show to give us all the juicy details of the 20th Anniversary of the drag and drive that started it all! If you are attending Drag Week, please come find Mike at the Summit truck, starting line or in the pits, and say Hi!!

In times of rising chronic diseases, and challenges, costs and threats to health care, Plant Powered Metro NY, a leading nutrition and health-focused nonprofit in New York, offers a powerful solution to treating and preventing chronic diseases. Our guest is Lianna Levine Reisner, President and Network Director, to talk about plant-powered diets as an evidence-based approach to well-being, and their Jumpstart Program, based on a whole food, plant based diet.

Microsoft and the Analytics Institute have awarded 150 people from 13 organisations with a DataSMART Foundation Credential in Data Skills following an interactive Datathon event hosted by Microsoft in Dublin on Friday (March 21). The event enabled the participants to apply newly acquired data skills in a collaborative environment, demonstrating the practical benefits of this innovative programme. DataSMART, developed by Technology Ireland DIGITAL Skillnet in partnership with Microsoft and the Analytics Institute, is a trailblazing data literacy initiative designed for non-IT professionals who want to harness data strategically in their roles. Research shows that employees with core data skills advance faster in their careers, while organisations making data-driven decisions achieve accelerated market progress and revenue growth. Major companies including Bord Gais, Pfizer and Flutter have already enrolled employees in the programme, recognising the competitive advantage of building organisation-wide data literacy. The 12-week DataSMART programme equips professionals with foundational skills in data collection, cleaning, transformation, visualisation, and storytelling, while exploring cutting-edge topics like AI, data governance and emerging technologies. It is ideal for non-IT professionals seeking to build confidence in using data. DataSMART is particularly beneficial for large groups from the same organisation, as peer learning interactions deepen understanding and application of data concepts across departments. The programme's flexible format combines online tutorials with interactive workshops, allowing working professionals acquire valuable data literacy competence in a cost-effective way that accommodates busy schedules. Commenting, Maire Hunt, Network Director of Technology Ireland DIGITAL Skillnet, said: "The DataSMART initiative has been a resounding success, helping individuals across all sectors build the confidence and skills needed to navigate today's data-driven world. This programme has proven to be an ideal solution for organisations looking to upskill large groups of employees efficiently, ensuring their workforce can interpret and apply data to make better business decisions. "With its flexible, accessible learning approach and practical applications, DataSMART has opened new opportunities for both individuals and businesses, reinforcing the vital role of data skills in future-proofing Ireland's workforce." Russell Kane, Datathon Facilitator, of Microsoft, said: "It was fantastic to deliver a number of the online modules and subsequently to facilitate the in-person mid-review workshop as well as the full-day in-person datathon. The blended delivery method of the course allowed the participants to work through the contents of the modules at their own pace, while the in-person sessions provided invaluable opportunities for hands-on learning and real-time interactions. "The importance of this course cannot be overstated when it comes to upskilling all staff in understanding the significance and impact of data, particularly in our rapidly evolving era of AI. DataSMART empowers individuals to navigate the complexities of data with confidence, making informed decisions and driving innovation within their organisations. As AI continues to transform many sectors, equipping employees with robust data skills ensures that they remain agile and competitive in a data-driven world." Lorcan Malone, CEO, Analytics Institute, added: "The completion of the DataSMART pilot programme marks an important milestone in advancing data literacy at scale. The positive response from participating organisations highlights the growing recognition that data skills are essential across all roles and industries. By providing a structured yet flexible approach to learning, DataSMART has helped integrate data-driven thinking into everyday decision-making. We are excited to see how this initiative continues to support businesses in building...

Our brains are one of the most adaptable and dynamic parts of the body. Brain injuries, however, can disrupt all facets of our lives from personality to relationships to how we move through the world. Even a minor concussion can have lingering effects to mood and executive functioning and attention that can slip under the radar. On this episode, I'm joined by a lived experiencer of traumatic brain injuries, Kayleigh Stack. She shares her story, not sparing any of the ups and downs and talks about managing pain and easing the nervous system.In this episode we discuss:the lesser known impacts of traumatic brain injuriesthe importance of nervous system regulationtypes of treatments for TBIhyperbaric oxygen treatmentdealing with chronic painthe power of story and resisting reductionist narrativesBioKayleigh is an activist, artist, community steward, and medicine woman. Over the past ten years, she has orchestrated spaces for people to share recorded audios of poignant histories and stories oriented around critical social and political narratives to be presented in an Oral History Performance Initiative: The Community Storytelling Composition Project. Above all else, she believes that sharing personal stories has the power to restore humanity and resuscitate life back into one another when in need. Because “if we don't share your stories, Who will?” (Mia Mingus 2018)Most of her work focuses on socio-political discourse, drawing upon performance as a subversive tool to generate conversation around a particular poignant or charged subject. Her educational background spans degrees in Sociology from Hunter College, NY, Anthropology from SUNY New Paltz, NY, a Masters in Traditional Chinese Medicine at Pacific College of Oriental Medicine where she became a Licensed Acupuncturist, and Masters of Oral History at Columbia University. Professional accomplishments include getting onto the Cirque du Soleil roster of Circus artists in 2014, Dance Oral Historian Assistant in New York Public Library's Library of Performing arts, Production Stage Manager with Roll the Bones Theatre at Dead Letter No. 9, Network Director of Zen Peacemakers International, and administration for a variety of reputable arts nonprofits. Currently she is Creative Learning Manager for the international civic production company, Forklift Danceworks. Outside of work, Kayleigh is often escaping into other worlds through reading, writing, or walking quietly in nature. Nowadays, mostly the latter.LinksKayleigh's  Linktreehyperbaric oxygen meta-analysis for tbi https://link.springer.com/article/10.1007/s10072-015-2460-2 & https://www.liebertpub.com/doi/abs/10.1089/neu.2017.5225Resources:Find videos and bonus episodes: ⁠DEPTHWORK.SUBSTACK.COM⁠Get the book: ⁠⁠Mad Studies Reader: Interdisciplinary Innovations in Mental Health⁠Become a member: ⁠The Institute for the Development of Human Arts⁠Train with us: ⁠Transformative Mental Health Core CurriculumSessions & Information about the host: ⁠⁠JazmineRussell.com⁠⁠Disclaimer: The DEPTH Work Podcast is for educational and entertainment purposes only. Any information on this podcast in no way to be construed or substituted as psychological counseling, psychotherapy, mental health counseling, or any other type of therapy or medical advice.

Fergal McCann, Chief Technology Officer with Eir and Sheila Kavanagh, Network Director with Vodafone Ireland discuss the damage Storm Éowyn caused to broadband and phone services.

A major data skills initiative to help thousands of non-IT Irish professionals to become data literate and keep pace with the digital revolution has been launched, supported by Technology Ireland Digital Skillnet in collaboration with Microsoft. Data SMART is aimed at equipping professionals across Ireland who do not work in IT-based roles with the confidence and essential data skills - or data literacy - that they need to thrive in today's workplace. Created by the Technology Ireland Digital Skillnet in association with the Analytics Institute and Microsoft, thousands of non-tech workers can now ensure that their skills are current and relevant to a digital future. Studies show that those staff that are familiar with core data skills will progress faster in their careers. Furthermore, research confirms that companies making data-driven decisions make faster market progress and revenue. Data SMART will allow working professionals to acquire data literacy competence in a flexible, low-cost way during a 12-week learning window that combines online tutorials with hands-on, interactive workshops. Participants will acquire skills in Data Collection and Cleaning, Data Transformation and Interpretation, Data Visualisation and Storytelling, as well as Ethics, Privacy, Security and Data Governance. A Data SMART Foundation Certificate in Data Skills will be awarded by the Analytics Institute and Microsoft to recognise participants' new data skills. Commenting at the launch of Data SMART in Microsoft HQ in Leopardstown, Dublin yesterday, Maire Hunt, Network Director of Technology Ireland Digital Skillnet, said: "Data SMART is the most ambitious national upskilling opportunity for companies to adopt essential data skills that has been created to date. Our ambition is to train over 10,000 professionals from all backgrounds and across all sectors over the next three years." Lorcan Malone, Analytics Institute CEO, said: "Already multiple companies have signed up for the Data SMART Initiative with companies able to train large numbers of staff in a very flexible, low-cost manner, with minimum impact on the flow of work. This will boost careers national and internationally, as well as enabling leaders to adopt a data driven approach to decisions in an increasing challenging commercial landscape." Microsoft, a world leader in technology, sees this initiative as a chance to equip Irish workers with practical data knowledge and provide a stepping stone to better skills and brighter career prospects. Microsoft Ireland Head of Future Skilling, Dr Kevin Marshall, said: "Microsoft Ireland is committed to providing upskilling opportunities for all. As organisations engage with the AI revolution, data analysis skills are fundamental. This initiative will equip individuals with crucial skills for effective data navigation and informed decision-making. We are pleased to collaborate with the Technolofgy Ireland Digital Skillnet and the Analytics Institute on this important programme." How to Apply for the Data SMART Initiative: Data SMART is open to workers in the Republic of Ireland with part-funding available from Technology Ireland Digital Skillnet. Spaces are limited, so interested professionals are encouraged to apply soon. For more information and to sign up, visit www.datasmart.digitalskillnet.ie More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie now to find out more about how we can help you reach our audience. You can also find and follow us on Twitter, LinkedIn, Facebook, Inst...

Steve is a UConn School of Law Graduate and currently works as the organizing and Network Director at the People's Parity Project. This episode dives into one of the most compelling journeys yet, showcasing how winding roads often lead to powerful destinations. Steve's story embodies the very essence of this podcast: that there's no straight pathway into the legal field, only your unique journey!We kicked things off nearly two decades before law school ever crossed Steve's mind. A Boston University chemistry major, Steve made a bold decision to leave school and join the US Army. Later, he returned to finish his degree and launched a career as a researcher and scientist. But it was a legal struggle with the US Army that opened his eyes to the power of the law—sparking a passion he didn't yet realize.While still immersed in his scientific career, Steve dedicated more of his time to veterans' legal services. Gradually, his love for science waned as his commitment to law grew. Eventually, Steve took the plunge and enrolled at UConn School of Law.Law school wasn't smooth sailing. Just as Steve began his 1L year, the birth of his child and a major car accident set him back by a month. Yet, he powered through, leveraging the discipline and problem-solving skills he'd honed as a scientist.Our conversation reveals his evolving interest in public interest law, a field that calls to him deeply. Steve's clear sense of purpose has been his compass, helping him find joy and resilience through every challenge.Today, Steve is part of the People's Parity Project, rallying law students nationwide to make real changes in public interest law. From veterans' rights to systemic reform, Steve's work inspires others to bring about meaningful change.His journey reaffirms something I've long believed: anyone, regardless of background, can step into the field of law and make an impact. Steve's story is proof.Steve's LinkedIn: https://www.linkedin.com/in/steve-kennedyBe sure to check out the Official Sponsors for the Lawyers in the Making Podcast:Rhetoric - takes user briefs and motions and compares them against the text of opinions written by judges to identify ways to tailor their arguments to better persuade the judges handling their cases. Rhetoric's focus is on persuasion and helps users find new ways to improve their odds of success through more persuasive arguments. Find them here: userhetoric.comThe Law School Operating System™ Recorded Course - This course is for ambitious law students who want a proven, simple system to learn every topic in their classes to excel in class and on exams. Go to www.lisablasser.com, check out the student tab with course offerings, and use code LSOSNATE10 at checkout for 10% off Lisa's recorded course!Start LSAT - Founded by former guest and 21-year-old super-star, Alden Spratt, Start LSAT was built upon breaking down barriers, allowing anyone access to high-quality LSAT Prep. For $110 you get yourself the Start LSAT self-paced course, and using code LITM10 you get 10% off the self-paced course! On top of that, Alden offers an upcoming 10-week course for the January LSAT. Using code LITM100 you get $100 off the 10-week course! Check out Alden and Start LSAT at startlsat.com and use both code LITM10 for 10% off the self-paced course, and LITM100 for $100 off the 10-week course! This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit lawyersinthemaking.substack.com

CitySwift, leader in performance optimisation for the public transport sector across the globe, has announced the continuation of its partnership with National Express West Midlands (NXWM). The three year extension comes following impressive year-on-year results, including improved bus punctuality and efficiencies. Since September 2023 NXWM's use of CitySwift's advanced AI and data technology has led to a reduction of more than 20% in late running, customer wait times have been reduced, and passengers per journey have increased. This follows strong results from previous years and consequently NXWM is now rolling out CitySwift's platform across its entire fleet of over 1,400 buses. As a leader in the largest UK urban bus market outside of London, NXWM provides on average 210 million bus passenger journeys per year across the West Midlands and has worked collaboratively with CitySwift to develop best-in-class transport solutions that analyse passenger and service data, drive optimum performance, and delivers a much more efficient use of resources. Speaking on today's announcement, Alan Farrelly, CCO and Co-founder of CitySwift said: "National Express West Midlands has been core to CitySwift's product development since 2019, and we are thrilled to extend our partnership for a further three years. This next phase will enable National Express West Midlands to further strengthen their commitment to enhancing the public transport network and improving the passenger experience through our technology." The latest innovative CitySwift solution is Spotlight, a globally leading intelligent recommendation engine for bus network enhancements that is integral to building smart cities and regions of the future. NXWM is the first UK transport operator to adopt Spotlight, with the West Midlands being the first region in the world to benefit, resulting in faster, more customer-centric choices that balance resources, passengers, cities, and operators. Ed Rickard, Network Director at National Express, commented: "Our collaboration with CitySwift to deliver Spotlight for the benefit of bus users across the West Midlands, and in major cities across the UK, is a groundbreaking achievement for the National Express West Midlands and CitySwift teams. We are delighted to continue working in partnership with CitySwift over the coming years and proudly leading the charge in the UK when it comes to the use of AI-powered data and insights that are key to an efficient, cost-effective delivery of bus service performance for customers across our network." Designed for schedulers; Spotlight improves scheduler decision-making by providing AI-powered insights into performance and resource considerations such as timeliness, cost, and vehicle numbers. It scans the entire network, delivering service optimisation options, and efficiency improvements. Andy Foster, Director of Bus Planning at National Express, added: "We are excited to be extending CitySwift's AI performance optimisation capabilities across our bus network in the West Midlands. Traffic conditions on our region's roads have worsened and can negatively impact the reliability of our services. However, using CitySwift's AI analytics and optimisation tools our skilled schedulers and network planners have been able to respond effectively, maximising our productivity and efficiency while also reducing late running for customers that rely on our bus services." Founded in 2016 by Brian O'Rourke and Alan Farrelly, CitySwift's performance optimisation platform gives operators and transport authorities insights, recommendations, and predictions, supporting them in the delivery of efficient, reliable and in-demand services. CitySwift empowers public transport operators and authorities to achieve unparalleled efficiency by leveraging advanced analytics, simulations, and optimisations. With its easy-to-use industry-leading technology, CitySwift envisions a future where public transport is the travel mode of choice ...

Cottage Baker, Author, Christian Women's Network Director and Entrepreneur extraordinaire, Kelly Campbell, is Erica's guest today - listen in as they talk about all things sourdough and making life easier for busy moms. Kelly will share how she started her business years ago and then rebuilt it after moving to Waco. Learn about life for the Campbell family in WacoTown and how Kelly is trying to make life a little easier for all us. Let her be busy so you don't have to be! Interested in her subscriptions or ordering bread or cinnamon rolls? Check out https://www.lookslikehomewithkelly.com and be sure to follow her on Social @lookslikehomewithkelly As always, if you have real estate questions or you're curious about the best ways to get plugged in here in Waco, please reach out to Erica - 254-447-0180 and follow the Boisvert's at @boisvertrealtyteam  Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Best Possible Taste Annie Dunne, founder of the art of GRATE food shares details about BrandBite, a free event for the food and drink industry in Ireland that is taking place on 22 May 2024. BrandBite is funded by the Taste 4 Success Skillnet and Network Director, Bridie Corrigan Matthews, provides an insight into the supports that Taste 4 Success offers to the food and drink industry in Ireland. BEST POSSIBLE TASTE IS IRELAND'S LONGEST RUNNING FOOD & DRINK RADIO SHOW & PODCAST & CELEBRATED 10 YEARS ON AIR IN 2023.

“The People Playbook: First, be clear about your goals and communicate with massive clarity to your team what you're trying to accomplish. Second, be brilliant at the basics." Andrew Bartlow is the co-founder of the People Leader Accelerator and the co-author of “Scaling for Success”. In this episode, Andrew discusses the common challenges faced by high-growth organizations and offers strategies for successful scaling. He emphasizes the significance of organizations creating a unique people's playbook and cautions against blindly adopting best practices from other companies. Andrew highlights 7 essential people practices organizations should prioritize, which includes organizational structure, learning & development, and culture & engagement.   Listen out for: Career Journey - [00:03:55] Writing “Scaling for Success” - [00:06:56] High-Growth Organization Challenges - [00:08:52] Goldilocks Zone - [00:11:11] People Playbook - [00:12:52] The Danger of Best Practices - [00:15:13] Crisis of Leadership & Autonomy - [00:17:29] Lack of Role Clarity - [00:21:34] 7 Key People Practices - [00:25:45] Key Practice: Organizational Structure - [00:30:44] Politics & Power Dynamics - [00:37:49] Key Practice: Learning & Development - [00:40:30] Key Practice: Culture, Engagement & Communications - [00:46:22] Sensing Employee Engagement - [00:52:17] 3 Tech Lead Wisdom - [00:55:14] _____ Andrew Bartlow's BioAndrew Bartlow has almost 25 years of experience as a thought leader in organizational effectiveness, and as a practical operator linking business strategy to HR priorities inside corporations. In addition to advisory and mentoring activities through Series B Consulting, Andrew serves as an Operating Partner & Senior Advisor for Altamont Capital Partners, the cofounder and Network Director for WiseGrowth Networks, the cofounder and Managing Partner of People Leader Accelerator, and an HR Venture Advisor for SemperVirens Venture Capital. Follow Andrew: LinkedIn – linkedin.com/in/bartlow People Leader Accelerator – peopleleaderaccelerator.com Series B Consulting – seriesbconsulting.com _____ Our Sponsors Manning Publications is a premier publisher of technical books on computer and software development topics for both experienced developers and new learners alike. Manning prides itself on being independently owned and operated, and for paving the way for innovative initiatives, such as early access book content and protection-free PDF formats that are now industry standard.Get a 45% discount for Tech Lead Journal listeners by using the code techlead45 for all products in all formats. Like this episode? Show notes & transcript: techleadjournal.dev/episodes/162. Follow @techleadjournal on LinkedIn, Twitter, and Instagram. Buy me a coffee or become a patron.

While AI stole the show in 2023 in terms of top federal IT trends and themes, cybersecurity — particularly adoption of zero trust — remained an essential focus across the federal government. While agencies are taking varied paths to modernizing their cybersecurity with zero-trust architectures, the Department of Commerce has taken perhaps the most aggressive and streamlined approach in moving to zero trust as one department, rather than letting bureaus and sub-agencies plot their own course. Andre Mendes, the outgoing CIO of the Commerce Department, spoke recently at CyberTalks giving an exclusive, deep-dive into the department's zero trust transformation. Mendes was joined by Blair Heiserman, CISO & Network Director at NIST, and Ron Ringgold, Commerce's Director of the Office of CyberSecurity Architecture Services, to share the department's journey.

REMIX: Album 2 Track 10 – Ellen Stone, EVP Marketing of NBC Lifestyle Brands, previously EVP of Marketing at Bravo Network, Director of Consumer Marketing at Lifetime and account person for notable Madison Ave. agencies Bozell and J. Walter Thompson. Graduate of Lehigh University.Hey Brand Nerds! We have an entertainment marketing legend in our house today!!  What a fun show with Ellen who shares great stories throughout her career from milk mustaches to certified bravolebrities to how to handle the deluge of people at Vanderpump Rules Bar Crawl and more. Oh and lots to learn including these highlights:  • Brand is a living thing and must always be fresh, innovative and be able to pivot • Learning the nuances and differences for brand positionings through the prism of NBCUniversal Lifestyle networks • When you have a “tight” brand, everyone who touches the brand gets it and success flows!• As a leader, ensure the team keeps it real with genuine feedback to you • When you have a poisonous person on your team, no matter how talented they are, gotta cut bait!• Bravoholics, Bravolebreties and Bravocon• Ellen and DC's British accent…#ellenstone #marketing #branding #NBCUniversal #bravo #bravotv #oxygen #E! #eentertainment #sociableshoppable #realhousewives #mrporter #vanderpumprules 

In this episode of The CX Tipping Point Podcast, Martha Dorris spoke with Dr. Indra Sandal, the Chief of Innovation at the Tampa Veterans Hospital and Mr. Greg Goins, the VISN 9 Network Director and Executive Sponsor of the VHA-Uber Health Connect Initiative. The Department of Veterans Affairs manages a very sophisticated innovation ecosystem that allows them to identify issues and pilot solutions in small ways to determine whether they should be scaled. In this example, they used it to provide veterans access to care.Based on feedback from veterans, VA identified “transportation” as a major cause for missed medical appointments. With 56% of veterans over the age of 65; 30% relying on their families, solving the transportation issue was a “must”. The VA has partnered with UberHealth to provide transportation to medical appointments. The goal of this program was to:Reduce no showsImprove their experience of veterans with convenience?Cost savings to VA hospitalsLearn how this initiative has been scaled to improve the health of veterans by serving more veterans; reducing the number of missed appointments; and saving the VA valuable funding as well.  Dr. Sandal and Mr. Goins provided some inspirational messages - nothing is too small and nothing is impossible. Dream big!!

Since the pandemic, more families are choosing to homeschool their children. In fact, homeschool enrollment has increased by nearly 30 percent. The most dramatic increase was seen with Black families with the number of homeschooled Black children rising from 3 percent to 16 percent in 2020.     Why is homeschooling on the rise? How can families know if homeschooling is right for them? And how can parents use their voice to find the best option for their children?   In this episode, Onnikah Randolph joins Kevin to discuss homeschooling and how parents can feel empowered to find the right option for their children.

I did things a little differently for the latest episode of Avry's Sports Show! I went back into the archives to bring to you an interview I did with Baggedmilk from OilersNation/Nation Network from October 2022! We got into a few Edmonton Oiler predictions, talking points, and the evolution of sports media in Canada. Follow Baggedmilk on Twitter: @jsbmbaggedmilk Hosted on Acast. See acast.com/privacy for more information.

Are you a disabled student? Disabled Students UK want you to share your experiences in the very first Annual Disabled Student Survey. Amelia talked to their Network Director, Amelia Mclaughlin, about accessibility in universities and having your say. Go to disabledstudents.co.uk/ to fill in the survey before the 21st July. Image: Bright green RNIB Connect Radio 20th Anniversary logo.

Sometimes, "Where do we draw the lines?" is asked out of sincere concern of falling down the slippery slope, especially in regards to believers who move away from hyper-fundamentalism. After all, if our pastor and church group don't draw the lines for us, who will? Other times, "Where do we draw the lines?" is asked as a way to use fear and shame to pressure believers into extra-biblical rules they are not "fully persuaded" of in their own minds (Romans 14:5). Either way, it's a question that deserves to be grappled with, and that's exactly what we do in this month's episode. Our guest is Nathan Mayo, cofounder of Berean Holiness and Network Director of True Charity. Also on the panel are Bethany, Andrew, and Natalie. Thank you for joining us as we rebuild theology in light of God's grace, love, and the true meaning of holiness! Have you registered for the Called to Freedom conference yet? Use promo code MAY50 for $50 off until May 31: BereanHoliness.com/conference Resources: "Where Do 'We Draw the Lines?" (Article) "Why Replace the Rules?" (Video) "Replacing Rules with Discipleship" (Article) "Looking Deeper into Discipleship" (Video) The "Not Ashamed" podcast is brought to you by Berean Holiness. You can find more of our content at: BereanHoliness.com "For I am not ashamed of the gospel, for it is the power of God for salvation to everyone who believes..." —Romans 1:16

We all know cities are a big contributor to light pollution. Charlotte Gage from Adfree Cities in the United Kingdom, contends that one of the biggest offenders is digital advertising. LED's are getting brighter and advertising signs are being left on all night, drowning out views of the night sky but also destroying people's sleep who live nearby these signs. Charlotte, Michael and John discuss what progress has been made, about how laws haven't caught up to digital signage, and how best to tackle this blight. Charlotte Gage is Network Director for Adfree Cities, a network of groups across the UK who are concerned about the impacts of corporate advertising on our health, wellbeing, environment, climate, communities and the local economy. Adfree Cities lobby for policy change at national and local levels, showcase alternatives, organize locally to stop new advertising sites in UK cities, and produce resources to raise awareness about the impacts of commercial advertising. 

Akshita Korwar, Software Developer at Hulu and Network Director of Women Who Code Seattle, interviews Sijing Zhu, Senior Data Science Manager at The Home Depot. They discuss the importance of continued learning, listening skills being a priority for success, and time management being key in accomplishing goals.

This episode features Ritika Kanade, Network Director for WomenWhoCode. Questions covered include: Tell us a bit about who you are, your background and journey in techWhat is Women Who Code? How did you get involved in WWC and what do you do with the org? How does WWC impact the community? How far have we come and what challenges still need to be addressed in the tech community?What's it like working for a tech giant? Any tips for other folks trying to get to a similar place in their career? What tools / technologies / or tech trends are you excited about right now? Ritika is a Software Engineer based in Seattle. She has worked at Rakuten in Fukuoka, Japan for ~3 years and was an Openlab Intern at CERN's IT-DB department in the summer of 2015. She is well travelled and enjoys learning new languages and cultures. She believes in equal opportunities and strongly advocates for education to all. She volunteers as a Network Director for WomenWhoCode in Seattle.

Jesus prayed that believers would be one, unified in Him (John 17:10-11, 20-23). But with so many different churches, denominations, and beliefs, how can believers have this unity today? What does excellent Christian unity look like practically? Can we collaborate across denominational lines without compromising our convictions? In this month's episode, we dive into all these questions and more. We are honored to have had the opportunity to compare perspectives with a Holiness Pentecostal minister, Luke Beets, in a moderated discussion. Luke is a college campus evangelist. You can find his content on Wake the Bride Podcast and The Beets College Campus Ministry. Representing the perspective of Berean Holiness and the Not Ashamed podcast is Nathan Mayo. Nathan is cofounder of Berean Holiness and currently serves as the Network Director of True Charity. We enjoy having respectful, productive discussions with ministers and social media influencers who disagree with us and/or have a differing perspective. If you fit this description and would like to have a public discussion with us, the invitation is extended! You may submit a request for public dialogue here or on our website via the link on our "Contact" page. "For I am not ashamed of the gospel, for it is the power of God for salvation to everyone who believes..." —Romans 1:16 Resources: A Closer Look at Christian Unity: Past, Present, At Home & Abroad Just How Christ-like is "Christian" Shunning? The "Not Ashamed" podcast is brought to you by Berean Holiness. You can find more of our content at: Bereanholiness.com Thanks for following on Facebook, Instagram, and YouTube Contact us at: bereanholiness@gmail.com

Here is my original video from when I started in IT https://youtu.be/mZJhHFj8gUoThis is how I was able to Land an I.T. Job With No Experience, No Degree, or No IT certifications. Then I was able to go from an entry-level help desk position in the IT field to becoming the Director of Network Operations in just 3 years. This is The Bearded I.T. Dad's origin story on what I did and all the advice to jump-start your career in Information Technology.  I talk about everything from which IT certification I studied for, resume tips, and how to stand out in the job market.  Support the show

Creating Sterile Processing Department schedules that make the most of a staff's time requires a complete understanding and visibility of the demands of a particular healthcare facility. And to gain that big picture, a department needs data and lots of it. Still, more than that, a Sterile Processing Department needs a platform solution that provides reporting in an innovative and actionable way.What's the next generation of technology available to make SPD scheduling demands less challenging?Tyler Kern, the host of ConCensis, came together with Seamus Johnson, Sr. Director of Application Development for Censis, Jeff Long, Network Director of Sterile Processing at St. Luke's University Health Network, and Cody Troutt, Director of Central Sterile at Williamson Medical for a third, and final discussion on Censis' new CensisAI2 Productivity platform. This third conversation with Kern, Johnson, Long, and Troutt includes the following:The importance of optimized SPD staff utilizationCreating tray efficiencies through data analysisAdvice for hospitals considering or evaluating the CensisAI2 tool“You have to be able to demonstrate to them (the C-Suite) a return on investment,” Troutt said. “It doesn't matter if you work for a for-profit or not-for-profit hospital. Your not-for-profit hospitals are not for a loss either.”Seamus Johnson is an experienced Senior Software Engineer with a demonstrated history of working in the hospital & healthcare industry. Johnson's proficiency in Software Architecture, Agile Methodologies, C#, Angular, and TypeScript makes him a valued asset to the Censis team, where he's spent most of his career.Jeff Long is an experienced Department Director with a demonstrated history of working in the hospital & healthcare industry. Long is skilled in Medical Devices, Infection Control, Orthopedics, Capital Equipment, and Healthcare. Strong business development professional with a Bachelor of Arts (BA) focused on Organizational Management and Leadership Development from Ashford University.Cody Troutt is an experienced Customer Service Manager with a demonstrated history of working in the hospital & healthcare industry. Troutt's a strong support professional skilled in Coaching, Medical Devices, Sales, Team Building, and HR Policies.

There are an estimated 51.4 million inpatient surgeries performed in the U.S. on an annual basis. That's a lot of reusable instruments that require sterile processing. It's no wonder Sterile Processing Departments (SPDs) have their hands full. Labor shortages, mainly since the pandemic, put tremendous strain on already taxed SPDs.Censis creates solutions to give SPD departments an edge in streamlined efficiency and data-driven analysis to provide actionable insights. Their latest solution, CensisAI2 Productivity, combines with CensiTrac to deliver SPDs with the complete visibility they need to increase productivity in sterile processing. Tyler Kern, the host of ConCensis, rejoined with Seamus Johnson, Sr. Director of Application Development for Censis, Jeff Long, Network Director of Sterile Processing at St. Luke's University Health Network, and Cody Troutt, Director of Central Sterile at Williamson Medical continued their discussion on the CensisAI2 Productivity solution.This second conversation with Kern, Johnson, Long, and Troutt includes the following:The challenges of visibility in operational processes for SPDsBest practices for utilizing CensisAI2 and CensiTracHow CensisAI2's dashboard helps SPD managers be proactive“One thing that we had realized was that our existing technology had not been optimized or even built,” Long said. “We had no standardization on how to use the technology we were using. We had a lot of work to do, and that's why the timing was perfect on a lot of the technology we incorporated since then.”Seamus Johnson is an experienced Senior Software Engineer with a demonstrated history of working in the hospital & healthcare industry. Johnson's proficiency in Software Architecture, Agile Methodologies, C#, Angular, and TypeScript makes him a valued asset to the Censis team, where he's spent most of his career.Jeff Long is an experienced Department Director with a demonstrated history of working in the hospital & healthcare industry. Long is skilled in Medical Devices, Infection Control, Orthopedics, Capital Equipment, and Healthcare. Strong business development professional with a Bachelor of Arts (BA) focused on Organizational Management and Leadership Development from Ashford University.Cody Troutt is an experienced Customer Service Manager with a demonstrated history of working in the hospital & healthcare industry. Troutt's a strong support professional skilled in Coaching, Medical Devices, Sales, Team Building, and HR Policies.

Many areas of healthcare struggle with staffing issues, requiring personnel to do more with fewer resources. Sterile processing departments are not immune to these issues. Today, increased responsibilities and difficulty finding and retaining qualified employees to manage these critical tasks are challenging to solve.Even with data tracking tools and platforms, making sense of all that collected data to take actionable steps to create efficiencies can take time and effort. So, what can sterile processing departments do?Tyler Kern, the host of ConCensis, welcomed three guests to the show to discuss the issue and a solution Censis created to work together with its CensiTrac Instrument Tracking System to provide actionable insights that will help streamline operations to achieve department goals. CensisAI2 Productivity is that solution, and on this first of three episodes, Seamus Johnson, Sr. Director of Application Development for Censis, Jeff Long, Network Director of Sterile Processing at St. Luke's University Health Network, and Cody Troutt, Director of Central Sterile at Williamson Medical laid the foundation for the need create productivity solutions for sterile processing departments.This first discussion with Kern, Johnson, Long, and Troutt includes the following:Why measuring productivity in sterile processing departments is essential.The staffing challenges SPD departments face in today's healthcare landscape.Validating staffing needs through actionable data.“Always have an elevator speech in your back pocket,” Troutt said. “Because you never know when you'll get on the elevator, and your chief, whatever title, will be there. And you must have that in your back pocket, ready to go all the time. Data is something that they'll most always listen to.”Seamus Johnson is an experienced Senior Software Engineer with a demonstrated history of working in the hospital & healthcare industry. Johnson's proficiency in Software Architecture, Agile Methodologies, C#, Angular, and TypeScript makes him a valued asset to the Censis team, where he's spent most of his career.Jeff Long is an experienced Department Director with a demonstrated history of working in the hospital & healthcare industry. Long is skilled in Medical Devices, Infection Control, Orthopedics, Capital Equipment, and Healthcare. Strong business development professional with a Bachelor of Arts (BA) focused on Organizational Management and Leadership Development from Ashford University.Cody Troutt is an experienced Customer Service Manager with a demonstrated history of working in the hospital & healthcare industry. Troutt's a strong support professional skilled in Coaching, Medical Devices, Sales, Team Building, and HR Policies.

Veteran's Day Special See omnystudio.com/listener for privacy information.

This episode features Lindsey Thompson, Network Director of Cardiovascular Programs at HonorHealth. Here, she discusses what led her to administrative leadership, how she foresees cardiovascular care evolving in the future, the importance of personalized care, and more.

This episode features Lindsey Thompson, Network Director of Cardiovascular Programs at HonorHealth. Here, she discusses what led her to administrative leadership, how she foresees cardiovascular care evolving in the future, the importance of personalized care, and more.

This episode features Lindsey Thompson, Network Director of Cardiovascular Programs at Honor Health. Here, she discusses what led her to administrative leadership, how she foresees cardiovascular care evolving in the future, the importance of personalized care, and more.

Susie Kumah joined the show to share all that God has been doing to grow the network of Alpha churches in the DMV.Susie Kumah is the Network Director of Alpha in the DMV (Washington D.C., Maryland and Virginia), who was born to Ghanaian parents, raised in London, and currently resides in Northern Virginia. Prior to joining Alpha USA, Susie worked as a worship leader at a Holy Trinity Church in McLean, VA. In addition, she managed both the outreach ministry and the Alpha course.Susie longs to see heartfelt praise and worship of God across the DMV. She hopes that everyone regardless of race, gender, age, class and more would experience the true love of God that would allow them to know Him abundantly…. As the Apostle Paul says in Ephesians 1:17, “I keep asking that the God of our Lord Jesus Christ, the glorious Father, may give you the Spirit  of wisdom and revelation, so that you may know him better.

Deepali Chouhan, Network Director for Women Who Code, Vancouver Canada, interviews Pooneh Mokariasl, Site Reliability Engineer at Criteo in Paris, France. They discuss the differences and similarities of Pooneh's engineering roles. They also discuss Criteo's Voyageurs program and the unique opportunity to explore working with other teams within the company.

Are you struggling with not seeing results or not seeing results stick? More often than not, this is a systems problem – not a spiritual problem. In this episode of Parallel Leaders Podcast, Kelly Stickel, Lead Pastor from Parallel Church, and Dr. Eric Smith, Lead Pastor at Hope City Church in Florida and author of Momentum: A Step-by-Step System for Growing a Healthy Church, take a deep dive into systems. Learn how to have clear vision and strategy, build a healthy culture, bring clarity, and implement measurements and accountability within your organization so incredible growth can take place and be sustained.   TOPICS INCLUDE: • Why should you create a "Momentum" type system • "Momentum System" overview. • The impact of the "Momentum" or EOS system in action. • Why you need to do a culture audit and how it can improve team trust. • Why your staff might be feeling frustrated. • Determining priorities when correcting your culture. • Creating measurements and metrics out of your values. • The power of a 100-minute meeting. • Lag Measures and Lead Actions   RESOURCES MENTIONED: ► Download the show notes:  ► FREE CULTURE AUDIT ► The Equip Group ► BOOK: Momentum by Eric Smith ► BOOK: Traction by Gino Wickman ► BOOK: 5 Dysfunctions of a Team by Patrick Lencioni ► 5 Voices System by GiANT Worldwide    Subscribe, rate and review to stay updated with the latest content!   CONNECT WITH PARALLEL LEADERS AT: ► Instagram: https://www.instagram.com/parallelleaders ► Facebook: https://www.facebook.com/parallelleaders ► Website: https://parallelleaders.com ► Kelly Stickel: https://kellystickel.com ► Subscribe to our weekly email for resources, relationships, coaching. https://linktr.ee/parallelleaders ABOUT ERIC SMITH: Dr. Eric Smith brings twenty years of ministry and leadership experience, with ten of those years as a Senior Pastor. He was a founder of Vertical Church, a church plant in Mississippi that became one of the fastest growing churches in the State which grew to four campuses. During that same time period, Eric was a founder of the 242 Network. The 242 Network is a church-planting network that assesses, trains, and coaches church planters primarily in Mississippi, but also around North America. During his time as the 242 Network Director, the team developed church planter assessments, training, and coaching. The 242 Network has now helped to plant over 50 churches and trained hundreds of church leaders. After almost seven years as a church planter and the 242 Network Director, Eric took on the task of revitalizing Vaughn Forest Church in Montgomery, AL, a church that had been declining for almost nine consecutive years. Under Eric's leadership and a powerful work of the Holy Spirit, the church saw the momentum change and within a year and a half was named to Outreach Magazine's “100 Fastest Growing Churches in America". During the past two years Eric has worked as a consultant serving churches and church plants around the country. Eric and Krystal believe God is calling their family to take a new step of faith and plant Hope City Church. 

Life is expensive right now; between inflation and rising interest rates, we have had a lot of people asking us how to manage family budgets. To get some advice, we speak to Derek McCormack, Network Director at Raising Children, about how to effectively budget for your family. Plus, Tegan and Leigh give their best penny pinching hacks, from rewards programs to saying 'no'. And, Leigh has a very embarrassing fail that involves being caught in the act by her son... THE END BITS  Subscribe to Mamamia Find out more on the Raising Children website GET IN TOUCH: Feedback? We're listening! Call the pod phone on 02 8999 9386 or email us at tgm@mamamia.com.au CREDITS: Host: Leigh Campbell & Tegan Natoli Producer: Emmeline Peterson Audio Engineer: Rhiannon Mooney Mamamia acknowledges the Traditional Owners of the Land we have recorded this podcast on, the Gadigal people of the Eora Nation. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander cultures. Just by reading our articles or listening to our podcasts, you're helping to fund girls in schools in some of the most disadvantaged countries in the world - through our partnership with Room to Read. We're currently funding 300 girls in school every day and we aim to get to 1,000. Find out more on mamamia.com.au  Become a Mamamia subscriber: https://www.mamamia.com.au/subscribe See omnystudio.com/listener for privacy information.

Jason Perkins is the Network Director for the Australian Irresistible Churches Network. Through years of leadership, he's experienced some of the highest highs and some of the lowest lows. In 2015, Jason accepted a lead pastor position at a North Point Strategic partner church in Colorado Springs where after years of growth in attendance, engagement, and giving, he came face to face with burn out. It was in this season that Jason realized the importance of soul care, and how it doesn't have to mean sacrificing your strategy or success. Jason is passionate emotionally healthy leadership and about helping leaders and teams reach their strategic goals without losing their souls. He spends his time outside of the Irresistible Churches Network offering coaching and consulting services to ministry leaders and their staff.

In the season 2 premiere, Teresa Basilio Gaztambide, the Network Director at MediaJustice joins Brandi and Steven to talk about a 90s Puerto Rican phenomenon. No we don't mean Ricky Martin! We do a deep dive on the legend of the Chupacabras aka The Goat Sucker. We also explore the political and cultural history of Canovanas, the city where the first sighting of the Chupacabras was recorded. Brandi introduces us to the legend of the Crichton Leprechaun, a sighting of the Irish supernatural being in the middle of a Black neighborhood in Alabama. Brandi and Steven debate which of these folk tales has the better lesson to teach us. What do you think? Resources from this episode:Imperial Secrets: Vampires and Nationhood in Puerto Rico by Lauren DerbyIt's Time to Retire The Crichton Leprechaun by Sharonda Harris-MarshallFollow us on social:Twitter: @bring_receiptsInstagram: @bring_receiptsWebsite: https://bringreceiptspodcast.comCreator & Host: Brandi Collins-Dexter (@BrandingBrandi)Host & Producer: Steven Renderos (@stevenrenderos)Artwork & Logo by: Andrés Guzmán (IG: andresitoguzman)Beats by: DJ RenDonate to our PatreonSupport the show

Successful Community and Political Activism is the cumulation of decades of dedications to the welfare of the community. In this month of Asian American Native Hawaiian Pacific Islander Heritage month, we have invited two exemplary Asian American trail blazers of Hmong Heritage to share their journeys and successful community building experiences with our audience. Our outstanding guests are Bo Thao-Urabe, Founder & former Network Director of the Coalition of Asian American Leaders Minnesota (CAALMN) KaYing Yang, former Director of Programs and Partnerships of the Coalition of Asian American Leaders Minnesota (CAALMN) Bo Thao-Urabe has served under President Obama on the Advisory Commission of the White House Initiative on AANHPI and KaYing was just appointed to the same position under President Biden. Mr. Rajeev Singh is our interviewer on this episode with introduction and takeaways by Mr. Jack Hanna. --- Send in a voice message: https://anchor.fm/aauc/message

WWCode Conversations: Nia Cortes, Network Director at Women Who Code Monterrey interviews Crystal Goade, Creative Director, User Experience at Shutterstock. They discuss Crystal's management experience, improving hiring, promotion, and retention of women in tech, and the role of designers as technology evolves. WWCode Career Nav: April is National Volunteer Month in the US so in this week's Women Who Code Career Nav segment we're highlighting some of the volunteers that are at the heart of our community, with a Women Who Code Asia Director Panel featuring WWCode Taipei Director Jane Shih, WWCode Tokyo Legacy Director Kate Gamo, WWCode Beijing Director YiQun Yun, WWCode Bangalore Director Shwetha Lakshman Rao, and WWCode Seoul Director Yujin Chung. Moderated by WWCode Chief Program Officer Shanna Gregory. WWCode Talks Tech: Friday is Earth Day! So let's get our green on in this week's Women Who Code Talks Tech segment about using code to reduce greenhouse gasses, with Rose Fenwick, a Data Scientist at OMD EMEA.

Join Jenny Salt as she ascends the heights and plumbs the depths of church planting with veteran Adam Ramsey.Adam has been involved in church planting for 15 years, including working in Seattle in the Mars Hill church alongside Mark Driscoll. He is also a pastor of a church that was planted on the Gold Coast in QLD, and he is the Network Director of Acts 29 for Asia Pacific - and he hasn't hit 40 yet!In his 'spare time', he's also written a book titled Truth on Fire: Gazing At God Until Your Heart Sings.Jenny discovers, though, that some of Adam's deepest lessons have come from processing failure rather than celebrating success.

Rajika Reed PhD., MPH, MEd, is the Vice President of Community Health at St. Luke's University Health Network. She has a background in epidemiology, serving in a prior role as Network Director of Epidemiology and Strategy at St. Luke's. Originally from Sri Lanka, Reed earned a bachelor's degree from Penn State University, a master's in public health from the University of Pittsburgh, a master's in Education from Lehigh University, and most recently, a Doctor of Philosophy in Instructional Design from Lehigh University.Subjects discussed include an explanation of community health, equity in healthcare, what St. Luke's does as a part of it's community health and outreach programs, social determinants of health, what populations are most impacted by inequity in healthcare, COVID-19 and it's impact on low-income communities, lifestyle related disease in these communities, Hispanic Center Lehigh Valley and more.https://www.slhn.org/

Philip Moore serves as the Network Director for Acts 29 Europe and he has recently been appointed as the VP for Global Networks. We spent some time catching up with him as he described the Acts 29 landscape and spoke to us about why he serves on the Acts 29 Southern-Africa board as well.  Philip reminded us that even though its a new year, and even as things change, Acts 29 continues to exists to plant Gospel-centred churches.Philip mentioned the Acts 29 Europe Conference and Global Gathering and you can find out more about this at:https://www.acts29.com/europeconference/For more information about Acts 29 Southern Africa, check out: https://www.acts29.com/network/southern-africa . If  you are interested in applying to plant a church with Acts 29 Southern-Africa, check out: https://application.acts29.com/courses/acts-29-application-preparing-to-plant-southern-africa-network-p2p-v21 . Or perhaps you are an existing church interested in joining our diverse family of church-planting churches, then check out: https://application.acts29.com/courses/existing-church-southern-africa-exca-v3

With the new year on the horizon, we end the last episode of 2021 with a conversation focused on creating work that is community-centered, asset-based solutions to ensure meaningful outcomes and lasting change. Bo shares her experiences about the classic immigrant child struggle of being the interpreter and translator for our elders while also figuring out her own voices as the first generation. As a Hmong American, representing about 0.09% of the U.S. population, Bo shares her leadership journey of finally saying "yes" to leading authentically after growing up being constantly told "no" she doesn't belong. Bo Thao-Urabe is the Founder and Network Director for the Coalition of Asian American Leaders (CAAL), which harnesses the collective power of Asian American leaders from sectors, generations and ethnicities to improve the lives of the community. She is also the Founder and Chief Operating Officer of RedGreen Rivers, a social enterprise connecting women artisans in Southeast Asia to global markets in order to preserve indigenous art forms and increase economic well-being of women and their families.  ________ CONNECT WITH BO Linkedin: linkedin.com/in/bothaourabe CAAL: caalmn.org RedGreen Rivers: facebook.com/RedGreenRivers ________ SUBSCRIBE TO LEAP @leapuncaptalent on https://www.instagram.com/leapuncaptalent/ (Instagram) / https://twitter.com/leapuncaptalent (Twitter) / https://www.linkedin.com/company/leapuncaptalent/ (Linkedin) / https://www.facebook.com/LEAPUncapTalent (Facebook) Learn more about us at https://www.leap.org/ (leap.com) ________ This episode was edited by Catt Phan

On this week's episode of 2 Jocks & A Schlub, the guys welcome Andrew Rotondi to the show. Andrew is the Network Director at Blue Wire and co-host of the Yankees podcast The Bronx Pinstripes Show. They all rant about the Yankees' offseason plans, what Aaron Boone can do to make his tenure work, and what the best and worst team losses are in their lifetimes. Follow the gang on Twitter! Podcast: @2Jocks1Schlub Colin: @cjcernig Matt: @rootycake Ethan: @eurtz23 FACEBOOK Group: https://www.facebook.com/2Jocks1Schlub Questions or suggestions for the show? Hit the mailbag: 2jocks1schlub@gmail.com Music via HookSounds.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

On this our final episode of season 2 of the podcast, we touch base once again with our very own Network Director, Pastor One Mokgatle. It's been a year since we spoke to One about Acts 29 Southern Africa and we thought that a great way to wrap up the season would be to check in with him. We spoke sabbaticals, soul care and all things Acts 29 Southern Africa. For more information about Acts 29 Southern Africa, check out: https://www.acts29.com/network/southern-africa . If  you are interested in applying to plant a church with Acts 29 Southern-Africa, check out: https://application.acts29.com/courses/acts-29-application-preparing-to-plant-southern-africa-network-p2p-v21 . Or perhaps you are an existing church interested in joining our diverse family of church-planting churches, then check out: https://application.acts29.com/courses/existing-church-southern-africa-exca-v3

The Future of Pharmacy Podcast, presented by Omnicell Pharmacy innovators are solving technician shortages with new, subscription models that include the technology, dedicated labor, integrated best practices, and expert services, to realize the promise of pharmacy automation. Guests:   Matt Baldwin, PharmD, System Pharmacy Director, Aultman Health Foundation  Dave Young, PharmD, Network Director of Inpatient Pharmacy, Einstein Healthcare Network Host: Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell All Episodes here: https://www.omnicell.com/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Heart by Waymarker is a monthly special about healthcare career journeys.  Sarah Rankin currently serves Community Health Network as Network Director of Patient Experience. Committed to making healthcare more understandable and continual improvement, Sarah is a certified Project Management Professional, Lean Six Sigma Black Belt, Master Change Management, and Kata Coach. In her almost nine years at Community Health Network, Sarah has served in roles like Epic Application Analyst and Performance Excellence Consultant, in addition to her current role leading patient experience. Sarah earned her BA in Psychology from Hanover College and MBA in Healthcare Management from WGU. In my research, I found this excerpt from a provider recommendation: “Ambitious, hard-working, and enthusiastic are just a few words to describe Sarah…each day she comes to work with a smile on her face ready to take on numerous challenging projects across our Network.” Sarah's success is no surprise, as you will learn after listening to this conversation. Her appearance as the first guest on Heart by Waymarker is very intentional; patient experience is at the heart of healthcare no matter what career journey we are discussing. I wanted to start these special talks about healthcare careers by taking a holistic and end-to-end view of the healthcare experience. That experience begins well before and continues well after the delivery of medical services. Waymarker, meet my friend Sarah Rankin! --- Support this podcast: https://podcasters.spotify.com/pod/show/waymarker/support

In this episode of Local Energy Rules, host John Farrell speaks with Liz Veazey, Network Director of We Own It, and Chris Woolery, Residential Energy Coordinator at the Mountain Association for Community Economic Development. The three discuss a new Rural Electric Co-op Toolkit and how it will help members democratize their co-ops. | Show page available: https://ilsr.org/rural-electric-coop-toolkit-ler-episode-89/ | Listen to all of our Local Energy Rules podcast episodes at our site: https://ilsr.org/local-energy-rules-podcast-homepage | Don't forget to subscribe, share with your friends, leave a recommendation on our podcast feeds, and join the conversation online using the #LocalEnergyRules hashtag!